Logo image of HCO.PA

HIGH CO (HCO.PA) Stock Fundamental Analysis

EPA:HCO - Euronext Paris - Matif - FR0000054231 - Common Stock - Currency: EUR

3.97  +0.1 (+2.58%)

Fundamental Rating

5

HCO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 62 industry peers in the Media industry. HCO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HCO has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year HCO was profitable.
In the past year HCO had a positive cash flow from operations.
HCO had positive earnings in each of the past 5 years.
Each year in the past 5 years HCO had a positive operating cash flow.
HCO.PA Yearly Net Income VS EBIT VS OCF VS FCFHCO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

1.2 Ratios

HCO's Return On Assets of 3.61% is fine compared to the rest of the industry. HCO outperforms 66.13% of its industry peers.
HCO has a Return On Equity (8.02%) which is comparable to the rest of the industry.
HCO has a better Return On Invested Capital (8.20%) than 74.19% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HCO is in line with the industry average of 8.25%.
Industry RankSector Rank
ROA 3.61%
ROE 8.02%
ROIC 8.2%
ROA(3y)3.3%
ROA(5y)3.33%
ROE(3y)7.47%
ROE(5y)7.73%
ROIC(3y)10.16%
ROIC(5y)10.01%
HCO.PA Yearly ROA, ROE, ROICHCO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 5.10%, HCO is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
In the last couple of years the Profit Margin of HCO has remained more or less at the same level.
Looking at the Operating Margin, with a value of 7.91%, HCO is in line with its industry, outperforming 58.06% of the companies in the same industry.
HCO's Operating Margin has declined in the last couple of years.
The Gross Margin of HCO (39.38%) is worse than 64.52% of its industry peers.
In the last couple of years the Gross Margin of HCO has declined.
Industry RankSector Rank
OM 7.91%
PM (TTM) 5.1%
GM 39.38%
OM growth 3Y-15.46%
OM growth 5Y-4.07%
PM growth 3Y-14.45%
PM growth 5Y-0.78%
GM growth 3Y-6.94%
GM growth 5Y-2.75%
HCO.PA Yearly Profit, Operating, Gross MarginsHCO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HCO is creating some value.
Compared to 1 year ago, HCO has less shares outstanding
HCO has less shares outstanding than it did 5 years ago.
The debt/assets ratio for HCO has been reduced compared to a year ago.
HCO.PA Yearly Shares OutstandingHCO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HCO.PA Yearly Total Debt VS Total AssetsHCO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 1.86 indicates that HCO is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of HCO (1.86) is better than 61.29% of its industry peers.
HCO has a debt to FCF ratio of 0.25. This is a very positive value and a sign of high solvency as it would only need 0.25 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.25, HCO belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that HCO is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.04, HCO belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Altman-Z 1.86
ROIC/WACC1.1
WACC7.44%
HCO.PA Yearly LT Debt VS Equity VS FCFHCO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.20 indicates that HCO should not have too much problems paying its short term obligations.
HCO has a Current ratio of 1.20. This is in the better half of the industry: HCO outperforms 62.90% of its industry peers.
A Quick Ratio of 1.20 indicates that HCO should not have too much problems paying its short term obligations.
HCO has a Quick ratio of 1.20. This is in the better half of the industry: HCO outperforms 69.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
HCO.PA Yearly Current Assets VS Current LiabilitesHCO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

HCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.18%.
The Earnings Per Share has been decreasing by -2.40% on average over the past years.
HCO shows a small growth in Revenue. In the last year, the Revenue has grown by 0.64%.
HCO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.59% yearly.
EPS 1Y (TTM)-29.18%
EPS 3Y-10.03%
EPS 5Y-2.4%
EPS Q2Q%-76.25%
Revenue 1Y (TTM)0.64%
Revenue growth 3Y2.12%
Revenue growth 5Y-3.59%
Sales Q2Q%0.43%

3.2 Future

HCO is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.41% yearly.
HCO is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.14% yearly.
EPS Next Y-16.94%
EPS Next 2Y-8.26%
EPS Next 3Y-6.41%
EPS Next 5YN/A
Revenue Next Year-3.49%
Revenue Next 2Y-1.83%
Revenue Next 3Y-1.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HCO.PA Yearly Revenue VS EstimatesHCO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
HCO.PA Yearly EPS VS EstimatesHCO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.18, the valuation of HCO can be described as reasonable.
Based on the Price/Earnings ratio, HCO is valued a bit cheaper than 77.42% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.28. HCO is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 15.52, which indicates a correct valuation of HCO.
The rest of the industry has a similar Price/Forward Earnings ratio as HCO.
HCO is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.18
Fwd PE 15.52
HCO.PA Price Earnings VS Forward Price EarningsHCO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HCO is valued cheaper than 98.39% of the companies in the same industry.
93.55% of the companies in the same industry are more expensive than HCO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.37
EV/EBITDA 0.37
HCO.PA Per share dataHCO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as HCO's earnings are expected to decrease with -6.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.26%
EPS Next 3Y-6.41%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.58%, HCO is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.99, HCO pays a better dividend. On top of this HCO pays more dividend than 83.87% of the companies listed in the same industry.
HCO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 6.58%

5.2 History

The dividend of HCO has a limited annual growth rate of 5.90%.
Dividend Growth(5Y)5.9%
Div Incr Years1
Div Non Decr Years1
HCO.PA Yearly Dividends per shareHCO.PA Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

HCO pays out 74.33% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of HCO has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP74.33%
EPS Next 2Y-8.26%
EPS Next 3Y-6.41%
HCO.PA Yearly Income VS Free CF VS DividendHCO.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HCO.PA Dividend Payout.HCO.PA Dividend Payout, showing the Payout Ratio.HCO.PA Dividend Payout.PayoutRetained Earnings

HIGH CO

EPA:HCO (7/2/2025, 7:00:00 PM)

3.97

+0.1 (+2.58%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)04-29 2025-04-29
Earnings (Next)07-22 2025-07-22
Inst Owners16.89%
Inst Owner ChangeN/A
Ins Owners16.32%
Ins Owner ChangeN/A
Market Cap81.23M
Analysts77.14
Price Target3.54 (-10.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.58%
Yearly Dividend0.28
Dividend Growth(5Y)5.9%
DP74.33%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)18.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.62%
Valuation
Industry RankSector Rank
PE 10.18
Fwd PE 15.52
P/S 0.55
P/FCF 3.37
P/OCF 3.3
P/B 0.87
P/tB 4.35
EV/EBITDA 0.37
EPS(TTM)0.39
EY9.82%
EPS(NY)0.26
Fwd EY6.44%
FCF(TTM)1.18
FCFY29.67%
OCF(TTM)1.2
OCFY30.28%
SpS7.15
BVpS4.55
TBVpS0.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.61%
ROE 8.02%
ROCE 11.25%
ROIC 8.2%
ROICexc 37.88%
ROICexgc N/A
OM 7.91%
PM (TTM) 5.1%
GM 39.38%
FCFM 16.46%
ROA(3y)3.3%
ROA(5y)3.33%
ROE(3y)7.47%
ROE(5y)7.73%
ROIC(3y)10.16%
ROIC(5y)10.01%
ROICexc(3y)33.2%
ROICexc(5y)64.31%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.94%
ROCE(5y)13.74%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y5.39%
ROICexc growth 5Y4.92%
OM growth 3Y-15.46%
OM growth 5Y-4.07%
PM growth 3Y-14.45%
PM growth 5Y-0.78%
GM growth 3Y-6.94%
GM growth 5Y-2.75%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Debt/EBITDA 0.18
Cap/Depr 7.6%
Cap/Sales 0.34%
Interest Coverage 250
Cash Conversion 135.83%
Profit Quality 322.93%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 1.86
F-Score6
WACC7.44%
ROIC/WACC1.1
Cap/Depr(3y)22.18%
Cap/Depr(5y)23.34%
Cap/Sales(3y)0.82%
Cap/Sales(5y)1.08%
Profit Quality(3y)322.39%
Profit Quality(5y)287.8%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.18%
EPS 3Y-10.03%
EPS 5Y-2.4%
EPS Q2Q%-76.25%
EPS Next Y-16.94%
EPS Next 2Y-8.26%
EPS Next 3Y-6.41%
EPS Next 5YN/A
Revenue 1Y (TTM)0.64%
Revenue growth 3Y2.12%
Revenue growth 5Y-3.59%
Sales Q2Q%0.43%
Revenue Next Year-3.49%
Revenue Next 2Y-1.83%
Revenue Next 3Y-1.14%
Revenue Next 5YN/A
EBIT growth 1Y-29.33%
EBIT growth 3Y-13.67%
EBIT growth 5Y-7.51%
EBIT Next Year1.49%
EBIT Next 3Y1.31%
EBIT Next 5YN/A
FCF growth 1Y122.14%
FCF growth 3Y35.54%
FCF growth 5Y0.35%
OCF growth 1Y92.44%
OCF growth 3Y31.82%
OCF growth 5Y-1.02%